Literature DB >> 27022915

Neurocognitive functioning in patients with glioma of the left and right temporal lobes.

Kyle R Noll1, Mateo Ziu2, Jeffrey S Weinberg3, Jeffrey S Wefel4.   

Abstract

Patients with glioma frequently suffer from deficits of neurocognitive functioning (NCF), though few studies have assessed NCF in localized glioma patients prior to surgery. One hundred and three patients (M age = 52.0; M education = 14.6 years) with histologically confirmed glioma in the right (RTL: n = 30; 57 % glioblastoma) or left temporal lobe (LTL: n = 73; 49 % glioblastoma) completed presurgical neuropsychological assessment. Impairment of NCF was identified in 75 % of all patients. Notably, patients with RTL glioma were most frequently impaired on measures of verbal memory and executive functioning, and at similar rates as the LTL group. Nonetheless, χ(2) tests revealed that impairment rates were significantly higher in the LTL group on attention and object naming tests (p ≤ .05). Independent-samples t-tests revealed that mean performances of patients with LTL glioma were also significantly below RTL patients on measures of attention (p = .01), verbal learning and memory (p = .05), and language (p < .03). A trend was observed in which anterior LTL tumors were associated with reduced verbal learning and medial LTL lesions with delayed recall problems, though patients with lesions involving multiple LTL regions exhibited the greatest difficulty across all verbal memory measures. Significant group differences in NCF performances remained so after controlling for FLAIR volume and tumor histology. These findings indicate that temporal lobe glioma frequently present with impaired NCF, though impairments are often milder in RTL compared to LTL patients. Nonetheless, the relatively frequent verbal memory impairment in the RTL group underscores the bilaterality of verbal memory processes.

Entities:  

Keywords:  Brain tumor; Cognition; Glioma; Temporal lobe

Mesh:

Year:  2016        PMID: 27022915      PMCID: PMC4884162          DOI: 10.1007/s11060-016-2114-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  31 in total

1.  Semantic memory is impaired in patients with unilateral anterior temporal lobe resection for temporal lobe epilepsy.

Authors:  Matthew A Lambon Ralph; Sheeba Ehsan; Gus A Baker; Timothy T Rogers
Journal:  Brain       Date:  2012-01       Impact factor: 13.501

2.  Memory and the medial temporal lobe: hemispheric specialization reconsidered.

Authors:  S Kennepohl; V Sziklas; K E Garver; D D Wagner; M Jones-Gotman
Journal:  Neuroimage       Date:  2007-04-04       Impact factor: 6.556

3.  Memory deficits after resection from left or right anterior temporal lobe in humans: a meta-analytic review.

Authors:  Tatia M C Lee; James T H Yip; Marilyn Jones-Gotman
Journal:  Epilepsia       Date:  2002-03       Impact factor: 5.864

4.  Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.

Authors:  Paul D Brown; Stephanie Pugh; Nadia N Laack; Jeffrey S Wefel; Deepak Khuntia; Christina Meyers; Ali Choucair; Sherry Fox; John H Suh; David Roberge; Vivek Kavadi; Soren M Bentzen; Minesh P Mehta; Deborah Watkins-Bruner
Journal:  Neuro Oncol       Date:  2013-08-16       Impact factor: 12.300

5.  Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study.

Authors:  M Klein; J J Heimans; N K Aaronson; H M van der Ploeg; J Grit; M Muller; T J Postma; J J Mooij; R H Boerman; G N Beute; G J Ossenkoppele; G W van Imhoff; A W Dekker; J Jolles; B J Slotman; H Struikmans; M J B Taphoorn
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

Review 6.  The neurobiology of cognitive disorders in temporal lobe epilepsy.

Authors:  Brian Bell; Jack J Lin; Michael Seidenberg; Bruce Hermann
Journal:  Nat Rev Neurol       Date:  2011-02-08       Impact factor: 42.937

7.  A randomized trial of bevacizumab for newly diagnosed glioblastoma.

Authors:  Mark R Gilbert; James J Dignam; Terri S Armstrong; Jeffrey S Wefel; Deborah T Blumenthal; Michael A Vogelbaum; Howard Colman; Arnab Chakravarti; Stephanie Pugh; Minhee Won; Robert Jeraj; Paul D Brown; Kurt A Jaeckle; David Schiff; Volker W Stieber; David G Brachman; Maria Werner-Wasik; Ivo W Tremont-Lukats; Erik P Sulman; Kenneth D Aldape; Walter J Curran; Minesh P Mehta
Journal:  N Engl J Med       Date:  2014-02-20       Impact factor: 91.245

8.  Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma.

Authors:  Terri S Armstrong; Jeffrey S Wefel; Meihua Wang; Mark R Gilbert; Minhee Won; Andrew Bottomley; Tito R Mendoza; Corneel Coens; Maria Werner-Wasik; David G Brachman; Ali K Choucair; Minesh Mehta
Journal:  J Clin Oncol       Date:  2013-10-07       Impact factor: 44.544

9.  Relationships between tumor grade and neurocognitive functioning in patients with glioma of the left temporal lobe prior to surgical resection.

Authors:  Kyle R Noll; Catherine Sullaway; Mateo Ziu; Jeffrey S Weinberg; Jeffrey S Wefel
Journal:  Neuro Oncol       Date:  2014-09-16       Impact factor: 12.300

10.  Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings.

Authors:  Karen Hilverda; Ingeborg Bosma; Jan J Heimans; Tjeerd J Postma; W Peter Vandertop; Ben J Slotman; Jan Buter; Jaap C Reijneveld; Martin Klein
Journal:  J Neurooncol       Date:  2009-08-30       Impact factor: 4.130

View more
  21 in total

1.  Hippocampal radiotherapy dose constraints for predicting long-term neurocognitive outcomes: mature data from a prospective trial in young patients with brain tumors.

Authors:  Jayant S Goda; Debnarayan Dutta; Uday Krishna; Savita Goswami; Vikas Kothavade; Sadhna Kannan; Madan Maitre; Nazia Bano; Tejpal Gupta; Rakesh Jalali
Journal:  Neuro Oncol       Date:  2020-11-26       Impact factor: 12.300

2.  Glioblastoma cells vampirize WNT from neurons and trigger a JNK/MMP signaling loop that enhances glioblastoma progression and neurodegeneration.

Authors:  Marta Portela; Varun Venkataramani; Natasha Fahey-Lozano; Esther Seco; Maria Losada-Perez; Frank Winkler; Sergio Casas-Tintó
Journal:  PLoS Biol       Date:  2019-12-17       Impact factor: 8.029

3.  'Moderate global aphasia': A generalized decline of language processing caused by glioma surgery but not stroke.

Authors:  Andrey Zyryanov; Ekaterina Stupina; Elizaveta Gordeyeva; Olga Buivolova; Evdokiia Novozhilova; Yulia Akinina; Oleg Bronov; Natalia Gronskaya; Galina Gunenko; Ekaterina Iskra; Elena Ivanova; Anton Kalinovskiy; Evgenii Kliuev; Dmitry Kopachev; Elena Kremneva; Oksana Kryuchkova; Igor Medyanik; Nikita Pedyash; Viktoria Pozdniakova; Igor Pronin; Kristina Rainich; Andrey Reutov; Anastasia Samoukina; Anastasia Shlyakhova; Andrey Sitnikov; Olga Soloukhina; Konstantin Yashin; Valeriya Zelenkova; Andrey Zuev; Maria V Ivanova; Olga Dragoy
Journal:  Brain Lang       Date:  2021-12-06       Impact factor: 2.381

4.  Working memory training for adult glioma patients: a proof-of-concept study.

Authors:  Sarah Ellen Braun; Farah J Aslanzadeh; Autumn Lanoye; Stephanie Fountain-Zaragoza; Mark G Malkin; Ashlee R Loughan
Journal:  J Neurooncol       Date:  2021-09-07       Impact factor: 4.130

5.  Comparison between inferior frontal gyrus intrinsic connectivity network and verb-generation task fMRI network for presurgical language mapping in healthy controls and in glioma patients.

Authors:  Sara Cirillo; Giovanni Battistella; Antonella Castellano; Francesco Sanvito; Antonella Iadanza; Michele Bailo; Raffaella Lina Barzaghi; Stefania Acerno; Pietro Mortini; Maria Luisa Gorno-Tempini; Maria Luisa Mandelli; Andrea Falini
Journal:  Brain Imaging Behav       Date:  2022-07-30       Impact factor: 3.224

6.  Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary utility in adult neuro-oncology.

Authors:  Ashlee R Loughan; Sarah E Braun; Autumn Lanoye
Journal:  Neurooncol Pract       Date:  2018-12-08

7.  Neurocognitive functioning is associated with functional independence in newly diagnosed patients with temporal lobe glioma.

Authors:  Kyle R Noll; Mariana E Bradshaw; Jeffrey S Weinberg; Jeffrey S Wefel
Journal:  Neurooncol Pract       Date:  2017-11-19

Review 8.  Cognitive impact of lower-grade gliomas and strategies for rehabilitation.

Authors:  Christina Weyer-Jamora; Melissa S Brie; Tracy L Luks; Ellen M Smith; Steve E Braunstein; Javier E Villanueva-Meyer; Paige M Bracci; Susan Chang; Shawn L Hervey-Jumper; Jennie W Taylor
Journal:  Neurooncol Pract       Date:  2020-11-04

9.  Subjective executive dysfunction in patients with primary brain tumors and their informants: relationships with neurocognitive, psychological, and daily functioning.

Authors:  Sarah Ellen Braun; Autumn Lanoye; Farah J Aslanzadeh; Ashlee R Loughan
Journal:  Brain Inj       Date:  2021-12-07       Impact factor: 2.311

Review 10.  Postacute Cognitive Rehabilitation for Adult Brain Tumor Patients.

Authors:  Christina Weyer-Jamora; Melissa S Brie; Tracy L Luks; Ellen M Smith; Shawn L Hervey-Jumper; Jennie W Taylor
Journal:  Neurosurgery       Date:  2021-11-18       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.